BH GSO ASTM F639:2022

ASTM F639:09(2015)
Bahraini Standard   Current Edition · Approved on 28 April 2022

Standard Specification for Polyethylene Plastics for Medical Applications

BH GSO ASTM F639:2022 Files

English 3 Pages
Current Edition Reference Language

BH GSO ASTM F639:2022 Scope

This specification covers the properties for polyethylene plastics for use in medical device applications involving human tissue contact devices, short term indwellings, and fluid transfer devices. Biocompatibility tests must be conducted on the final products as the biocompatibility of these materials as a class has not been established. Plyethylene plastics should consist of basic polymers with ethylene as essentially the sole monomer. The compound may contain optional adjuvant substances required in polymer production or fabrication. The final compound should yield a consistent absorption spectrum characteristic of the established formulation. The polyethylene plastics should be tested using the specified physical test procedures for density, melt flow, tensile properties, compressive properties, stiffness, flexural fatigue, and other flexural properties.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
BH GSO 2017:2023
GSO 2017:2023 
Bahraini Standard
Personal Care and Baby Wet Wipes
BH GSO 2241:2023
GSO 2241:2023 
Bahraini Standard
Cosmetic Products - Body Cleaners
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners

Recently Published from Health Sector

GSO ISO 23217:2025
ISO 23217:2024 
Gulf Standard
Injection systems for self-administration by paediatric patients — Requirements and guidelines for design
GSO ISO 20611:2025
ISO 20611:2018 
Gulf Standard
Adventure tourism — Good practices for sustainability — Requirements and recommendations
GSO ISO 8536-13:2025
ISO 8536-13:2024 
Gulf Standard
Infusion equipment for medical use — Part 13: Graduated flow regulators for single use with fluid contact
GSO ISO 18562-3:2025
ISO 18562-3:2024 
Gulf Standard
Biocompatibility evaluation of breathing gas pathways in healthcare applications — Part 3: Tests for emissions of volatile organic substances